Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab and Genexine Announce China NMPA Clearance for Phase 2 Clinical Trial of TJ107/HyLeukin-7™ in Glioblastoma Multiforme 2020-05-21 20:00
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology 2020-05-21 08:58
China Biologic Comments on the Xinjiang Deyuan and Shuanglin Transaction 2020-05-21 04:45
China Biologic Reports Financial Results for the First Quarter of 2020 2020-05-21 04:30
Macrogen Approved for Export of its COVID-19 Test Kit 2020-05-20 21:00
I-Mab Expands Global Presence with New Hong Kong Office 2020-05-20 16:00
Samsung Biologics Expands Business Continuity Excellence with Additional ISO22301 Certification 2020-05-20 07:11
SciMount announces FDA approval of SMP-100's IND application for the treatment of Irritable Bowel Syndrome 2020-05-14 18:00
First Patient Dosed with I-Mab's CD73 Antibody TJD5 in Phase 1/2 Clinical Trial in China for Advanced Solid Tumors 2020-05-13 20:00
ChemPartner Assists the Mount Sinai Health System in Producing Reagent for COVID-19 Research 2020-05-12 23:03
China Biologic Products to Report First Quarter 2020 Financial Results 2020-05-12 20:30
HJB and Mabspace Biosciences' Development and Manufacturing Agreement for Novel Humanized Claudin18.2 Monoclonal Antibody Accomplished FDA and NMPA IND Clearance 2020-05-08 23:00
Bridge Biotherapeutics Announces the IND Clearance of BBT-176, an EGFR TKI for NSCLC, in South Korea 2020-05-08 07:30
Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report 2020-04-30 16:35
Fosun Pharma Invites Chinese and Foreign Experts to Jointly Discuss Prevention and Control Measures of COVID-19 Epidemic in Africa 2020-04-30 00:50
Gracell Reports Data of First-in-human Clinical Trial for Universal TruUCAR™ GC027 in Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Virtual Annual Meeting 2020-04-29 04:00
CARsgen Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for Fully Human Anti-BCMA CAR-T Cells (CT053) for the Treatment of Multiple Myeloma 2020-04-27 18:00
Samsung Biologics and ImmuneOncia Therapeutics Inc. Development and Manufacturing Agreement Accomplishes IND Clearance of IMC-002 (anti-CD47 antibody) 2020-04-23 08:00
Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE™ Orphan Drug Designation for Neuroblastoma 2020-04-21 21:13
Transcenta Received IND Clearance from FDA for Initiating Clinical Trials for its Novel Humanized Claudin 18.2 Monoclonal Antibody TST001 2020-04-20 23:00
1 120 121 122 123 124 165